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Background
Methysergide has been the prophylactic drug of last
resort at the Princess Margaret Migraine Clinic for
many years. In Boston I reviewed the records of 38
patients, 27 with migraine and 11 cluster headache,
including 11 who had been taking it continuously, in
some cases for as long as ten years. The distribution of
methysergide ceased in May 2013, and supplies
dwindled in Britain during the autumn of 2013.
I have reviewed the 2013-4 records of these 11 patients,
as well as an additional 4 (3 migraine and 1 cluster head-
ache) who had started methysergide under our supervision
during the early months of 2013. Two of the 13 migraine
patients had remitted spontaneously, and in a further one
the drug seemed to have lost efficacy; the remaining 10
and both the cluster patients were worse.
The European Medicines Agency have acknowledged
the value of methysergide1, recommending that all
patients are registered so that screening tests for fibrotic
complications are undertaken regularly. The British Asso-
ciation for the Study of Headache will be arranging this;
no doubt comparable arrangements will be set up in other
countries. The British company Amdipharm holds a distri-
bution licence for methysergide covering most of Europe;
they hope to restore it to the market soon.
Conclusions
These findings suggest that there will be always be a
significant number of patients who would benefit from
the drug.
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